September 2024 FDA Recall Proparacaine Hydrochloride by Mckesson Medical-surgical Inc. Corporate Office
D-0661-2024 - Temperature abuse

This Class II drug recall was voluntarily initiated by Mckesson Medical-surgical Inc. Corporate Office on September 11, 2024 for the product Proparacaine Hydrochloride. The FDA reported the reason for recall as temperature abuse. The product was distributed in Product was distributed to two medical facilities in MD and VA. and the recall is currently terminated.

Recall Number: D-0661-2024

Reason for Recall
Temperature abuse: Products exposed to improper temperature above drug label specifications.
Initiated
09-11-2024
Reported
10-02-2024
Quantity
27 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Mckesson Medical-Surgical Inc. Corporate Office
Product was distributed to two medical facilities in MD and VA.
Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (sterile), 15 mL bottle, Rx only, MFG: Bausch & Lomb, NDC 24208-730-06

Batch or Lot Expiration Information

Lot# 476261, 479751, 479741, Exp 3/31/2026

Affected Packages Involved in this Recall